Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:OBLN

Obalon Therapeutics (OBLN) Stock Price, News & Analysis

Obalon Therapeutics logo

About Obalon Therapeutics Stock (NASDAQ:OBLN)

Key Stats

Today's Range
$6.16
$6.63
50-Day Range
$2.36
$7.64
52-Week Range
$0.66
$10.77
Volume
251,503 shs
Average Volume
7.68 million shs
Market Capitalization
$62.49 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive OBLN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Obalon Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

OBLN Stock News Headlines

InterWest Management Partners X, LLC's Net Worth
Obalon Therapeutics, Inc.
Prepare for the “Mar-a-Lago Accord” Money Shock
Why Are Wall Street Insiders Moving Their Money to This ONE Asset? Something far more consequential for your money than tariffs is unfolding behind the scenes... Tucked inside this overlooked directive is a plan set to be executed for the first time in in U.S. history. One Stansberry Research's Senior Partner says it's set to trigger a rare window for potentially explosive gains in ONE asset immediately. (Not AI or crypto). Wall Street insiders are already positioning themselves... and he insists you should, too, before it's too late.tc pixel
Spero Therapeutics Inc.
Renovare Environmental Inc (RENO)
See More Headlines

OBLN Stock Analysis - Frequently Asked Questions

Obalon Therapeutics, Inc. (NASDAQ:OBLN) released its quarterly earnings results on Thursday, March, 11th. The company reported ($0.17) earnings per share for the quarter, missing analysts' consensus estimates of ($0.06) by $0.11. The firm had revenue of $0.06 million for the quarter. Obalon Therapeutics had a negative net margin of 776.76% and a negative trailing twelve-month return on equity of 161.38%.

Obalon Therapeutics shares reverse split on Thursday, July 25th 2019.The 1-10 reverse split was announced on Wednesday, July 24th 2019. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, July 24th 2019. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Obalon Therapeutics (OBLN) raised $75 million in an initial public offering (IPO) on Thursday, October 6th 2016. The company issued 5,000,000 shares at a price of $14.00-$16.00 per share. UBS Investment Bank, Canaccord Genuity and Stifel served as the underwriters for the IPO and BTIG was co-manager.

Based on aggregate information from My MarketBeat watchlists, some other companies that Obalon Therapeutics investors own include Inovio Pharmaceuticals (INO), Vaxart (VXRT), Canopy Growth (CGC), Plug Power (PLUG), NIO (NIO), NVIDIA (NVDA) and OPKO Health (OPK).

Company Calendar

Last Earnings
3/11/2021
Today
9/21/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Surgical & Medical Instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:OBLN
CIK
1427570
Fax
N/A
Employees
2
Year Founded
2008

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$12.33 million
Net Margins
-776.76%
Pretax Margin
N/A
Return on Equity
-161.38%
Return on Assets
-83.58%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.86
Quick Ratio
1.86

Sales & Book Value

Annual Sales
$1.59 million
Price / Sales
39.30
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.60 per share
Price / Book
10.39

Miscellaneous

Outstanding Shares
10,022,000
Free Float
N/A
Market Cap
$62.49 million
Optionable
Not Optionable
Beta
-1.23

Social Links

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

This page (NASDAQ:OBLN) was last updated on 9/22/2025 by MarketBeat.com Staff
From Our Partners